INTEGRIN RECEPTORS FOR EXTRACELLULAR MATRIX IN PERI-IMPLANTATION DEVELOPMENT
INTEGRIN RECEPTORS FOR EXTRACELLULAR MATRIX IN PERI-IMPLANTATION DEVELOPMENT
批准号:
6272165
负责人:
CAROLINE H DAMSKY
金额:
$17.29万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-02-01 至 1999-01-31
关键词:
cell cell interaction cell cycle cell differentiation chimeric proteins collagenase decidua diploidy early embryonic stage ectoderm embryo /fetus tissue /cell culture embryo implantation embryonic stem cell endoderm extracellular matrix proteins genetically modified animals genotype human tissue immunocytochemistry integrins laboratory mouse protein structure function receptor expression somatomammotropin transcription factor trophoblast
中文摘要
细胞外基质(ECM)受体在调节
发育过程中的形态发生。 整合素超家族
异二聚体跨膜受体包括ECM的两个家族
受体:β 1和α V整合素。 这些受体具有
多个重叠的配体偏好,表明功能性的
冗余或精确的特异性。 在目前的资助期内,我们
已经表明植入前小鼠胚胎表达至少两种α V,
- 和两个β 1相关的整合素。
这两个家族的其他成员都在β-
着床期:到第7.5天,例如,滋养层(TB)来源的
外胎盘锥和次级巨细胞表达至少7个α V
和β 1整联蛋白复合物。 α V整合素存在于
在孵化的囊胚外,在一个位置上发挥作用,
初始植入,而α V和β 1整联蛋白都是
在胚胎的其他区域检测到。 我们消除了β 1整合素
在小鼠胚胎中的基因打靶。 β 1缺失胚胎形成a
正常的胚泡并开始着床 然而,他们死在
植入后早期。 Beta1-null的形态发生分析
体外胚胎研究提出了几种假设:a)α V和β 1
整联蛋白在TB和ICM分化中发挥独特的作用,
形态发生 B)β 1整联蛋白为细胞提供存活信号,
ICM,导致ICM在围着床期死亡。 c)、
结核病最初并不依赖β 1生存,但未能发展
此外,在初始植入后,由于缺乏来自
ICM。 d)细胞外配体结合和细胞质信号
β 1整联蛋白亚基的转导结构域是
恢复正常的胚胎发育。 来验证这些假设
我们将:1)确定特定的alphaV与Beta1的功能
整合素在结核病形态发生中的体外和体内正常和β 1-
无效胚胎 2)确定β 1整合素在ICM中的功能
分化 实验将评估β 1整联蛋白在
ICM存活和分化为胚外内胚层,
原始胚胎外胚层谱系。 3)确定最大
体内β 1缺失TB和ICM谱系的分化能力,
在体外,使用含β 1嵌合体和无β 1嵌合体的胚胎,以及
β 1-null胚胎干细胞 4)确定在多大程度上生存和
通过重建β 1-null,
具有β 1亚基的胚胎,其中含有截短或改变的β 1
胞质结构域 这种方法应该恢复β 1-整联蛋白配体
结合并延长胚胎存活,但揭示了Beta1的独特特征
影响形态发生、组织特异性
分化和/或生长控制。 β 1缺失胚胎分析
形态发生将涉及与项目III的广泛互动,
六. 我们将扩展整合素表达的研究,
与项目II合作,
和VI. 这些研究应该可以增加对正常的理解。
围着床期发育,并显示细胞-ECM相互作用
有助于形成胚外谱系,
在怀孕期间成功的胎儿和母亲的沟通。
英文摘要
Extracellular matrix (ECM) receptors play critical roles in regulating
morphogenesis during development. The integrin superfamily of
heterodimeric transmembrane receptors includes two families of ECM
receptors: the Beta1 and alphaV integrins. These receptors have
multiple, overlapping ligand preferences, suggesting either functional
redundancy, or exquisite specificity. In the present grant period, we
have shown that preimplantation mouse embryos express at least two alphaV
- and two Beta1-associated integrins from the outset of development.
Additional members of both families are upregulated in the peri-
implantation period: by d7.5, for example, the trophoblast (TB)-derived
ectoplacental cone and secondary giant cells express at least 7 alphaV
and Beta1 integrin complexes. alphaV integrins are present on the
outside of the hatched blastocyst, in a position to play a role in
initial implantation, whereas both alphaV and Beta1 integrins are
detected in other areas of the embryo. We eliminated the Beta1 integrin
family in mouse embryos by gene targeting. Beta1-null embryos form a
normal blastocyst, and initiate implantation. However, they die in the
early postimplantation period. Analysis of morphogenesis of Beta1-null
embryos in vitro suggests several hypotheses: a) alphaV and Beta1
integrins play distinctive roles in TB and ICM differentiation and
morphogenesis. b) Beta1 integrins provide a survival signal for the
ICM, resulting in death of the ICM in the peri-implantation period. c)
TB is not initially Beta1-dependent for survival, but fails to develop
further after initial implantation due to the lack of signals from the
ICM. d) Both the extracellular ligand binding, and cytoplasmic signal
transducing domains of the Beta1 integrin subunit are required for the
restoration of normal embryonic development. To test these hypotheses
we will: 1) Determine the functions of specific alphaV vs. Beta1
integrins in TB morphogenesis in vitro and in vivo in normal and Beta1-
null embryos. 2) Determine the functions of Beta1 integrins in ICM
differentiation. Experiments will assess the role of Beta1 integrins in
ICM survival, and differentiation to extraembryonic endoderm and
primitive embryonic ectoderm lineages. 3) Determine the maximum
differentiation capacity of Beta1 null TB and ICM lineages in vivo and
in vitro, using chimeric Beta1-containing and Beta1-null embryos, and
Beta1-null embryo stem cells. 4) Determine to what extent survival and
further embryonic development are restored by reconstituting Beta1-null
embryos with Beta1 subunits that contain a truncated or altered Beta1
cytoplasmic domain. This approach should restore Beta1-integrin ligand
binding and extend embryo survival, but reveal unique features of Beta1
integrin signaling that affect morphogenesis, tissue specific
differentiation and/or growth control. Analysis of Beta1-null embryo
morphogenesis will involve extensive interactions with Projects III and
VI. We will extend studies of integrin expression in the peri-
implantation period to human embryos in collaboration with Projects II
and VI. Together these studies should increase understandings of normal
peri-implantation development and show how cell-ECM interactions
contribute to forming the extraembryonic lineages that result in
successful fetal-maternal communication during pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTEGRIN/ECM INTERACTIONS IN BONE FORMATION AND REMODELING
-
批准号:6662811
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2002
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN RECEPTORS FOR EXTRACELLULAR MATRIX IN PERI-IMPLANTATION DEVELOPMENT
-
批准号:6341018
-
项目类别:
-
资助金额:$18.05万
-
财政年份:2000
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY AND REPAIR
-
批准号:6175883
-
项目类别:
-
资助金额:$215.28万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY AND REPAIR
-
批准号:6198146
-
项目类别:
-
资助金额:$25.07万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY AND REPAIR
-
批准号:2797533
-
项目类别:
-
资助金额:$189.86万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN/ECM INTERACTIONS IN BONE FORMATION AND REMODELING
-
批准号:6349078
-
项目类别:
-
资助金额:$17.62万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY AND REPAIR
-
批准号:6523862
-
项目类别:
-
资助金额:$228.12万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN/ECM INTERACTIONS IN BONE FORMATION AND REMODELING
-
批准号:6153642
-
项目类别:
-
资助金额:$18.51万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN RECEPTORS FOR EXTRACELLULAR MATRIX IN PERI-IMPLANTATION DEVELOPMENT
-
批准号:6108549
-
项目类别:
-
资助金额:$18.05万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY AND REPAIR
-
批准号:6379900
-
项目类别:
-
资助金额:$220.48万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN/ECM INTERACTIONS IN BONE FORMATION AND REMODELING
-
批准号:6300876
-
项目类别:
-
资助金额:$13.56万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN/ECM INTERACTIONS IN BONE FORMATION AND REMODELING
-
批准号:6481895
-
项目类别:
-
资助金额:$11.95万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY AND REPAIR
-
批准号:6662599
-
项目类别:
-
资助金额:$218.94万
-
财政年份:1999
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN-EXTRACELLULAR MATRIX INTERACTIONS AND OSTEOBLAST DIFFERENTIATION
-
批准号:6104827
-
项目类别:
-
资助金额:$9.14万
-
财政年份:1998
-
负责人:CAROLINE H DAMSKY
-
依托单位:
ROLE OF ALPHA2BETA1 IN OSTEOBLAST FUNCTION AND DIFFERENTIATION
-
批准号:6268317
-
项目类别:
-
资助金额:$9.36万
-
财政年份:1998
-
负责人:CAROLINE H DAMSKY
-
依托单位:
CONFERENCE ON FIBRONECTIN, INTEGRINS & RELATED MOLECULES
-
批准号:2724771
-
项目类别:
-
资助金额:$3.5万
-
财政年份:1998
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN-EXTRACELLULAR MATRIX INTERACTIONS AND OSTEOBLAST DIFFERENTIATION
-
批准号:6270321
-
项目类别:
-
资助金额:$21.29万
-
财政年份:1997
-
负责人:CAROLINE H DAMSKY
-
依托单位:
NEW STRATEGIES FOR ENHANCING TISSUE INTEGRITY/REPAIR
-
批准号:2396844
-
项目类别:
-
资助金额:$14.7万
-
财政年份:1997
-
负责人:CAROLINE H DAMSKY
-
依托单位:
INTEGRIN RECEPTORS FOR EXTRACELLULAR MATRIX IN PERI-IMPLANTATION DEVELOPMENT
-
批准号:6241102
-
项目类别:
-
资助金额:$16.82万
-
财政年份:1997
-
负责人:CAROLINE H DAMSKY
-
依托单位:
ROLE OF ALPHA2BETA1 IN OSTEOBLAST FUNCTION AND DIFFERENTIATION
-
批准号:6235672
-
项目类别:
-
资助金额:$9.33万
-
财政年份:1997
-
负责人:CAROLINE H DAMSKY
-
依托单位:
海外基金